Younger 2027 Contest Challenges Participants to Reverse Biological Aging in Six Months
NeuroAge Therapeutics launches a science-backed competition measuring biological age across brain, body, and face using clinical-grade tools.
Summary
NeuroAge Therapeutics has launched Younger 2027, a six-month competition where participants measure their biological age using clinical-grade testing, attempt to reverse it through personal interventions, and get retested. The panel includes epigenetic clocks from TruDiagnostic, Harvard's FaceAge AI model, cognitive assessments, VO2 max, grip strength, and body composition scans. An Ultra tier adds brain MRIs, proteomics, and 100+ biomarker panels. Backed by researchers from MIT, Harvard, Yale, and Stanford, the contest kicks off January 2027 in San Francisco and concludes in November 2027. A $50,000 prize pool rewards those who achieve the greatest biological age reversal. Baseline kits ship September 1, 2026.
Detailed Summary
Younger 2027 is a structured biological aging competition designed to push participants to measurably reduce their biological age over six months using evidence-based interventions. Hosted by NeuroAge Therapeutics in collaboration with TruDiagnostic, Harvard FaceAge, and Vero Bioscience, the contest represents one of the most comprehensive citizen-science aging experiments attempted at scale.
Every competitor receives a clinical-grade baseline panel covering epigenetic aging clocks, organ-system aging scores across 11 systems via TruDiagnostic's SymphonyAge, cognitive assessments, Harvard's AI-powered FaceAge model, and functional fitness metrics including VO2 max and grip strength. Ultra-tier participants also receive two brain MRIs, DEXA body composition scans, proteomic aging clocks, and over 100 clinical biomarkers — several of which are pre-release tools not yet publicly available.
The contest structure is straightforward: establish a biological age baseline, run a six-month personal intervention window using any combination of diet, exercise, sleep, supplements, or therapeutics, then retest on the identical panel. A composite score tracks change between baseline and retest, enabling direct comparison across participants.
For longevity enthusiasts, the appeal is access to cutting-edge biological age measurement tools typically reserved for clinical trials or high-cost longevity clinics. Speakers at the January 2027 San Francisco kickoff include Dr. Steve Horvath, the pioneer of epigenetic clocks, alongside researchers from Harvard, Yale, and Stanford.
Key caveats: this is a competitive event, not a randomized controlled trial, so results will reflect self-selected interventions without controls. Biological age scores can fluctuate due to measurement noise, illness, or lifestyle disruptions unrelated to deliberate interventions. Participants should interpret composite score changes cautiously and consult clinicians before undertaking aggressive intervention protocols. Registration closes September 1, 2026 for early-bird pricing.
Key Findings
- Participants measure biological age across brain, body, and face using clinical-grade epigenetic, cognitive, and functional tools.
- Ultra tier includes pre-release proteomic and methylation clocks, brain MRIs, and 100+ biomarker panels not yet publicly available.
- Six-month intervention window lets competitors test any personal protocol — diet, exercise, supplements, or therapeutics — before retesting.
- Science contributors include researchers from MIT, Harvard, Yale, and Stanford, with Dr. Steve Horvath among confirmed speakers.
- A $50,000 prize pool rewards participants achieving the greatest measurable biological age reversal.
Methodology
This is a press release and event announcement, not a peer-reviewed study. The source, Lifespan.io, is a credible longevity-focused nonprofit publication. Evidence basis rests on established tools like TruDiagnostic's epigenetic clocks and Harvard's FaceAge model, both with published validation literature.
Study Limitations
This is a competitive event without randomization or control groups, limiting scientific inference about which interventions cause observed changes. Biological age scores carry measurement variability, and short-term fluctuations may not reflect true aging trajectory shifts. Prospective participants should verify panel costs, data privacy policies, and methodology details directly at neuroagetx.com.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: